Resistance to Ibritumomab in Lymphoma

Resistance to Ibritumomab in Lymphoma

This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumom...

Full description

Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Hosono, Makoto (Editor, http://id.loc.gov/vocabulary/relators/edt), Chatal, Jean-François (Editor, http://id.loc.gov/vocabulary/relators/edt)
Format: Electronic eBook
Language:English
Published: Cham : Springer International Publishing : Imprint: Springer, 2018.
Edition:1st ed. 2018.
Series:Resistance to Targeted Anti-Cancer Therapeutics, 18
Subjects:
Cancer research.
Cancer Research.
Online Access:Full Text via HEAL-Link
Description
Summary:This volume, in discussing resistance to ibritumomab, will focus on the mechanism, hematological aspects, radiological and nuclear medicine aspects, and medical physics that deal with radiation dosimetry, and will outline future prospects for overcoming resistance and enhancing efficacy of ibritumomab.
Physical Description:XIII, 158 p. 18 illus., 14 illus. in color. online resource.
ISBN:9783319782386
ISSN:2196-5501 ;
DOI:10.1007/978-3-319-78238-6

Similar Items